Analysts Viewpoint
Understanding the Risks of Investing in Arcus Biosciences Inc (RCUS)
Arcus Biosciences Inc’s filing revealed that its Director KANEKO YASUNORI acquired Company’s shares for reported $0.2 million on Feb 27
Menu
Arcus Biosciences Inc’s filing revealed that its Director KANEKO YASUNORI acquired Company’s shares for reported $0.2 million on Feb 27
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Arcus Biosciences Inc’s filing revealed that its Director KANEKO YASUNORI acquired Company’s shares for reported $0.2 million on Feb 27
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Arcus Biosciences Inc’s recent filing unveils that its Director KANEKO YASUNORI acquired Company’s shares for reported $0.2 million on Feb
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Arcus Biosciences
Arcus Biosciences Inc’s recent filing unveils that its Director KANEKO YASUNORI acquired Company’s shares for reported $0.2 million on Feb
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Arcus Biosciences Inc. (NYSE:RCUS) does about 1.18M shares in volume on a normal day but saw 853343 shares change hands